Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T23:10:45.525Z Has data issue: false hasContentIssue false

Improvement in psychological wellbeing among adolescents with a substance use disorder attending an outpatient treatment programme

Published online by Cambridge University Press:  08 April 2021

N.M. Gamage*
Affiliation:
Health Service Executive, Youth Drug & Alcohol Service, Dublin, Ireland
C. Darker
Affiliation:
Department of Public Health & Primary Care, Institute of Population Health, School of Medicine, Trinity College, Dublin, Ireland
B.P. Smyth
Affiliation:
Department of Public Health and Primary Care, Trinity College, Dublin, Ireland
*
*Address for correspondence: Health Service Executive, Youth Drug & Alcohol Service, Tallaght, Dublin 24, Ireland. (Email: nimantha5@hotmail.com)

Abstract

Objectives:

Adolescents with substance use disorders (SUDs) exhibit high rates of comorbid psychological problems. This study aimed to examine the impact of an outpatient substance use treatment programme upon the psychological wellbeing of adolescents.

Methods:

A prospective study was carried out examining psychological symptoms in a group of adolescents attending the Youth Drug and Alcohol (YoDA) Addiction Service in Dublin. Participants were treated with evidenced based psychological models such as cognitive behavioural therapy, motivational interviewing and systemic family therapy. The Becks Youth Inventory was utilised to assess psychological symptoms at treatment entry and repeated three months later at follow up.

Results:

Among 36 adolescents who were included in this study, poly-substance misuse was the norm. Almost three-quarter had a cannabis use disorder (CUD). There were significant reductions in mean subscale scores of depression (56.0 to 50.8, p = 0.003), anger (55.2 to 49.5, p < 0.001) and disruptive behaviour (61.6 to 56.5, p = 0.002) at follow up. Although there wasn’t a statistically significant reduction in mean scores for anxiety, we observed a significant proportion of participants (p = 0.008) improving and moving out of a moderate to severe symptom range when examined by category. This was also the case for self-concept (p = 0.04). Furthermore this study revealed a positive correlation between the reduction in days of cannabis use and reduction in depressive scores (Pearson correlation 0.49, p = 0.01) among those with a CUD.

Conclusion:

The findings indicate that substance use treatment for adolescents is associated with important psychological and behavioural improvements.

Type
Original Research
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The College of Psychiatrists of Ireland

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bates, G (2017). The Drugs Situation in Ireland: An Overview of Trends from 2005 to 2015. Liverpool John Moores University, Centre for Public Health.Google Scholar
Beck, JS, Beck, AT, Jolly, JB, Steer, RA (2005). Beck Youth Inventories Second Edition for Children and Adolescents Manual. Harcourt Assessment: San Antonio, TX.Google Scholar
Bellerose, D, Carew, AM, Lyons, S (2011). Trends in Treated Problem Drug Use in Ireland 2005 to 2010. Health Research Board. Alcohol and Drug Research Unit: Dublin.Google Scholar
Brook, JS, Whiteman, M, Cohen, P, Shapiro, J, Balka, E (1995). Longitudinally predicting late adolescent and young adult drug use: childhood and adolescent precursors. Journal of the American Academy of Child & Adolescent Psychiatry 34, 12301238.CrossRefGoogle Scholar
Bukstein, O, Brent, D, Kaminer, Y (1989). Comorbidity of substance abuse and other psychiatric disorders in adolescents. American Journal of Psychiatry 146, 11311141.Google ScholarPubMed
Chan, Y, Dennis, ML, Funk, RR (2008). Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment 34, 1424.CrossRefGoogle ScholarPubMed
Dennis, M, Godley, SH, Diamond, G, Tims, FM, Babor, T, Donaldson, J, Liddle, H, Titus, JC, Kaminer, Y, Webb, C, Hamilton, N, Funk, R (2004). The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. Journal of Substance abuse Treatment 27, 197213.CrossRefGoogle ScholarPubMed
Edokpolo, O, James, P, Kearns, C, Campbell, A, Smyth, BP (2010). Gender differences in psychiatric symptomatology in adolescents attending a community drug and alcohol treatment program. Journal of Psychoactive Drugs 42, 3136.CrossRefGoogle ScholarPubMed
Godley, SH, Meyers, RJ, Smith, JE, Karvinen, T, Titus, JC, Godley, MD, Dent, G, Passetti, L, Kelberg, P (2001). Adolescent Community Reinforcement Approach for Adolescent Cannabis Use. Substance Abuse and Mental Health Services Administration: Rockville, MD.Google Scholar
Hides, L, Carroll, S, Catania, L, Cotton, SM, Baker, A, Scaffidi, A, Lubman, DI (2010). Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people. Journal of Affective Disorders 121, 169174.CrossRefGoogle ScholarPubMed
Horigian, VE, Weems, CF, Robbins, MS, Feaster, DJ, Ucha, J, Miller, M, Werstlein, R (2013). Reductions in anxiety and depression symptoms in youth receiving substance use treatment. The American Journal on Addictions 22, 329337.CrossRefGoogle ScholarPubMed
Hser, Y, Grella, CE, Hubbard, RL, Hsieh, SC, Fletcher, BW, Brown, BS, Anglin, MD (2001). An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry 58, 689.CrossRefGoogle ScholarPubMed
Hser, Y, Mooney, LJ, Huang, D, Zhu, Y, Tomko, RL, McClure, E, Chou, CP, Gray, KM (2017). Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 81, 5358.CrossRefGoogle Scholar
Kaminer, Y, Bukstein, OG (2008). Adolescent Substance Abuse: Psychiatric Comorbidity and High-Risk Behaviors. Routledge: New York.Google Scholar
Keane, L, Ducray, K, Smyth, BP (2014). Psychological characteristics of heroin dependent and non-opioid-substance-dependent adolescents in community drug treatment services. Journal of Child & Adolescent Substance Abuse 23, 205209.CrossRefGoogle Scholar
Knudsen, HK (2009). Adolescent-only substance abuse treatment: availability and adoption of components of quality. Journal of Substance Abuse Treatment 36, 195204.CrossRefGoogle ScholarPubMed
Marsden, J, Eastwood, B, Wright, C, Bradbury, C, Knight, J, Hammond, P (2010). How best to measure change in evaluations of treatment for substance use disorder. Addiction 106, 294302.CrossRefGoogle ScholarPubMed
Marsden, J, Gossop, M, Stewart, D, Best, D, Farrell, M, Lehmann, P, Edwards, C, Strang, J (1998). The Maudsley Addiction profile (MAP): a brief instrument for assessing treatment outcome. Addiction 93, 18571867.CrossRefGoogle ScholarPubMed
Melnick, G, De Leon, G, Hawke, J, Jainchill, N, Kressel, D (1997). Motivation and readiness for therapeutic community treatment among adolescents and adult substance abusers. The American Journal of Drug and Alcohol Abuse 23, 485506.CrossRefGoogle ScholarPubMed
Miller, WR, Tonigan, JS (1996). Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors 10, 8189.CrossRefGoogle Scholar
Rohde, P, Turner, CW, Waldron, HB, Brody, JL, Jorgensen, J (2016). Depression change profiles in adolescents treated for comorbid depression/substance abuse and profile membership predictors. Journal of Clinical Child & Adolescent Psychology 47, 595607.CrossRefGoogle ScholarPubMed
Saddichha, S, Schütz, CG, Sinha, BNP, Manjunatha, N (2015). Substance use and dual diagnosis disorders: future epidemiology, determinants, and policies. BioMed Research International 2015, 12.CrossRefGoogle ScholarPubMed
Schaub, MP, Henderson, CE, Pelc, I, Tossmann, P, Phan, O, Hendriks, V, Rowe, C, Rigter, H (2014). Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: outcomes of the INCANT trial. BMC Psychiatry 14, Article 26, p. 26.CrossRefGoogle ScholarPubMed
Smyth, BP, Ducray, K, Cullen, W (2018). Changes in psychological well-being among heroin-dependent adolescents during psychologically supported opiate substitution treatment. Early Intervention in Psychiatry 12, 417425.CrossRefGoogle ScholarPubMed
Smyth, BP, Kelly, A, Barry, J, Cullen, W, Darker, C (2015). Treatment outcome for adolescents abusing alcohol and cannabis: how many “Reliably Improve”? Irish Medical Journal 108, 137139.Google Scholar
Stevens, SJ, Estrada, B, Murphy, BS, McKnight, KM, Tims, F (2004). Gender difference in substance use, mental health, and criminal justice involvement of adolescents at treatment entry and at three, six, 12 and 30 month follow-up. Journal of Psychoactive Drugs 36, 1325.CrossRefGoogle Scholar
Swann, WB, Read, SJ (1981). Self-verification processes: How we sustain our self-conceptions. Journal of Experimental Social Psychology 17, 351372.CrossRefGoogle Scholar
Tims, FM, Dennis, ML, Hamilton, NJ, Buchan, B, Diamond, G, Funk, R, Brantley, LB (2002). Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction, 97, 4657.CrossRefGoogle ScholarPubMed
Vitali, M, Sorbo, F, Mistretta, M, Scalese, B, Porrari, R, Galli, D, Coriale, G, Rotondo, C, Solombrino, S, Attilia, ML (2018). Dual diagnosis: an intriguing and actual nosographic issue too long neglected. Rivista di Psichiatria 53, 154159.Google ScholarPubMed
WHO ASSIST Working Group (2002). The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 97, 11831194.CrossRefGoogle Scholar
Winters, K, Kaminer, Y (2011). Adolescent behavioral change: process and outcomes. In Clinical Manual of Adolescent Substance Abuse Treatment (ed. Kaminer, Y and Winters, KC), pp.143162. American Psychiatric Publishing: Washington, DC.Google Scholar